Evidence map›Paper›PMID 40134590›Full record

ArticleFrontiers in oncology2025

Knowledge, attitudes, and practices regarding the postoperative management and TSH suppression therapy among patients with thyroid cancer.

Yongkang Wu, Zhi Zhang, Wenyi Qin, Weijie Chen, Tuo Xu

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yongkang WuDepartment of Vascular and Thyroid Surgery, the Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Zhi ZhangDepartment of Vascular and Thyroid Surgery, the Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Wenyi QinDepartment of Vascular and Thyroid Surgery, the Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Weijie ChenDepartment of Vascular and Thyroid Surgery, the Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.
Tuo XuDepartment of Vascular and Thyroid Surgery, the Affiliated Hospital of Guangdong Medical University, Zhanjiang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patient adherence to thyroid-stimulating hormone (TSH) suppression therapy is crucial for optimizing prognosis. Methods: This study aimed to examine the knowledge, attitude, and practice (KAP) toward TSH suppression therapy among patients. This cross-sectional study was conducted at our Hospital between March 2023 and October 2023 and included patients receiving TSH suppression therapy. A self-designed questionnaire was employed to collect their demographic characteristics and KAP. The analysis included 528 valid questionnaires. Results: The mean knowledge, attitude, and practice scores were 11.66 ± 5.82 (possible range: 0-22), 33.31 ± 4.97 (possible range: 0-40), and 24.46 ± 3.46 (possible range: 0-34), respectively, indicating poor knowledge, favorable attitudes, and moderate practice. The knowledge scores were correlated to the attitude (r=0.399, P<0.001) and practice (r=0.401, P<0.001) scores, while the attitude scores were correlated to the practice scores (r=0.512, P<0.001). The structural equation modeling revealed that knowledge directly influenced attitude (β=0.34, P<0.001) and practice (β=0.13, P<0.001) and indirectly influenced practice through attitude (β=0.10, P<0.001). Conclusions: Patients receiving TSH suppression therapy in Zhanjiang demonstrated poor knowledge, favorable attitudes, and moderate practices toward TSH suppression therapy.

Indexed as

attitudecross-sectional studyknowledgepracticethyroid cancerthyroid-stimulating hormone

Identifiers

PMID40134590
PMCPMC11933125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.